ResMed Completes $340 Million Acquisition of Noctrix Health

Global sleep and breathing health company ResMed has finalized its acquisition of Noctrix Health in a deal valued at up to $340 million, marking a notable expansion of its product and therapy offerings in the sleep health space. The transaction, which closed recently, brings Noctrix Health’s tonic motor activation (TOMAC) therapy platform under the ResMed […]

The post ResMed Completes $340 Million Acquisition of Noctrix Health first appeared on HHM Global | B2B Online Platform & Magazine.